Second malignancies in young children with primary brain tumors following treatment with prolonged postoperative chemotherapy and delayed irradiation: A Pediatric Oncology Group study

Annals of Neurology

Volumn 44, Issue 3, 1998, Pages 313-316

  Duffner, Patricia K ^a,g   Krischer, Jeffrey P ^b   Horowitz, Marc E ^c   Cohen, Michael E ^a   Burger, Peter C ^d   Friedman, Henry S ^e   Kun, Larry E ^f  

^a UNIVERSITY AT BUFFALO   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ARTICLE; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; DRUG EFFECT; FEMALE; GENE DELETION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MONOSOMY 7; NEUROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SECOND CANCER; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HUMANS; INFANT; NEOPLASMS, SECOND PRIMARY; POSTOPERATIVE PERIOD; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT;

EID: 0031663660     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440305     Document Type: Article

References (23)

1. Spunberg JJ, Chang CH, Goldman M, et al. Quality of long-term survival following irradiation for intracranial tumors in children under the age of two. Int J Radiat Oncol Biol Phys 1981;7:727-736
2. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than 3 years of age with malignant brain tumors: a Pediatric Oncology Group study. N Engl J Med 1993;328:1725-1731
3. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481
4. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analyses and examples. Br J Cancer 1977;35:1-39
5. Cantor A. Extending SAS survival analysis techniques for medical research. Cary, NC: SAS Institute, 1997:27
6. Duffner PK, Kun LE, Burger PC, et al. Postoperative chemotherapy and delayed radiation in infants and very young children with choroid plexus carcinomas. Pediatr Neurosurg 1995; 22:189-196
7. Bachman DS, Ostrow Pt. Fatal long-term sequelae following radiation "cure" for ependymoma. Ann Neurol 1978;4:319-321
8. Bogdanowicz WM, Sachs E. The possible role of radiation in oncogenesis of meningioma. Surg Neurol 1974;2:379-383
9. Pearl GS, Mirra SS, Miles ML. Glioblastoma multiforme occurring 13 years after treatment of a medulloblastoma. Neurosurgery 1980;6:546-551
10. Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features. J Clin Oncol 1986;4:1748-1757
11. LeBeau MM, Albain KS, Larson RA, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-345
12. Pederson-Bjergaard JP, Philip P, Larsen SO, et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen Series. Leukemia 1993;7:1975-1986
13. Smith MA, Rubinstein L, Ungerleider RS. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks. Med Pediatr Oncol 1994;23: 86-98
14. Pui CH, Behm FG, Raimondi SC, et al. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 1989;321:136-142
15. Pui CH, Ribeiro RC, Hancock ML, et al. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 1991;325:1682-1687
16. Ratain MJ, Kaminer LS, Bitran JD, et al. Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung. Blood 1987;70:1412-1417
17. Tucker MA, Meadows AT, Boice JD Jr, et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst 1987;78:459-464
18. Pui CH, Hancock ML, Raimondi SC, et al. Myeloid neoplasia in children treated for solid tumours. Lancet 1990;336:417-421
19. Van Eys J, Cangir A, Coody D, et al. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3:237-243
20. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985;3:532-538
21. Miser J, Krailo M, Smith M, et al. Secondary leukemia or myelodysplastic syndrome following therapy for Ewing's sarcoma. Proc Am Soc Clin Oncol 1997;16:1863 (Abstract)
22. Hudson MM, Jones D, Boyett J, et al. Late mortality of long-term survivors of childhood cancer. J Clin Oncol 1997;15: 2205-2213
23. Packer R, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81: 690-698